Clinical Outcome Following Prostatic Capsule- And Seminal-Sparing Cystectomy For Bladder Cancer In 25 Men

Main Category: Urology / Nephrology
Also Included In: Cancer / Oncology
Article Date: 28 Dec 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


UroToday.com - In a recent article in the Scandinavian Journal of Urology and Nephrology, the authors evaluated the long-term outcomes of 25 men who underwent a prostate capsule- and seminal-sparing cystectomy. They hypothesized that this approach would improve continence and potency.

Twenty-five male patients underwent cystectomy with preservation of the seminal vesicles, posterior prostate and neurovascular bundles. Orthotopic neobladders were performed in all patients. At the time of last follow-up, patients were interviewed in a standard fashion to evaluate urinary, bowel and sexually related symptoms.

During the follow-up period (mean 72 months, range 33-129) five patients developed metastases and died of bladder cancer. Four men were diagnosed with concomitant prostate cancer. Complete day-time continence was reported in 17/20 (85%) patients. Complete nocturnal continence was seen in 10/20 (50%) men. A total of 20/21 (95%) were sexually active following prostate-sparing cystectomy.

The authors concluded that prostatic capsule- and seminal-sparing cystectomy appears to combine an acceptable oncological outcome with satisfactory function of the lower urinary tract. A significant problem is that 4 out of 25 men developed, or were diagnosed with prevalent prostate cancer. If prostate capsule-sparing surgery is contemplated, preoperative prostate biopsies are needed to exclude the presence of prostate cancer.

Thorstenson A, Corey O'Connor R, Ahonen R, Jonsson MN, Wijkstrom H, Akre O, Hosseini A, Peter Wiklund N, Henningsohn L
Scand J Urol Nephrol. 2008 Nov 27:1-6

Written by UroToday.com Contributing Editor David P. Wood, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday

Article adapted by Medical News Today from original press release.
Visit our urology / nephrology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Urotoday. "Clinical Outcome Following Prostatic Capsule- And Seminal-Sparing Cystectomy For Bladder Cancer In 25 Men." Medical News Today. MediLexicon, Intl., 28 Dec. 2008. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/133754.php>

APA
Urotoday. (2008, December 28). "Clinical Outcome Following Prostatic Capsule- And Seminal-Sparing Cystectomy For Bladder Cancer In 25 Men." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/133754.php.

Please note: If no author information is provided, the source is cited instead.


Urology / Nephrology

Most Popular Articles



Follow Our Urology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Urology / Nephrology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »